Global Implantable Drug Infusion Pumps Market Insights and Forecast to 2028

Market Analysis and Insights: Global Implantable Drug Infusion Pumps Market
Due to the COVID-19 pandemic, the global Implantable Drug Infusion Pumps market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Patient-Controlled Analgesia (PCA) Pumps accounting for % of the Implantable Drug Infusion Pumps global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Oncology segment is altered to an % CAGR throughout this forecast period.
China Implantable Drug Infusion Pumps market size is valued at US$ million in 2021, while the US and Europe Implantable Drug Infusion Pumps are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Implantable Drug Infusion Pumps landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Implantable Drug Infusion Pumps include B. Braun Melsungen, Johnson & Johnson, Medtronic, Baxter International, Smiths Medical, CareFusion Corporation, Fresenius Kabi, Terumo Corporation and MOOG and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Implantable Drug Infusion Pumps Scope and Segment
Implantable Drug Infusion Pumps market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Implantable Drug Infusion Pumps market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Patient-Controlled Analgesia (PCA) Pumps
Enteral Pumps
Insulin Pumps
Elastomeric Pumps
Syringe Pumps
Segment by Application
Oncology
Pediatrics/Neonatology
Gastroenterology
Hematology
Diabetes
By Company
B. Braun Melsungen
Johnson & Johnson
Medtronic
Baxter International
Smiths Medical
CareFusion Corporation
Fresenius Kabi
Terumo Corporation
MOOG
Hospira
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE